Following brain damage, such as a stroke, a loss of speech (called aphasia) can occur. With the neolexon Aphasia App, you can practice at home for free in addition to your speech therapy – and as much as you like! Your speech therapy exercises are always readily available on your tablet or PC.
The self-training program is individually tailored to your personal needs and the severity of your speech disorder by your speech therapist. Setting up the self-training program is completely free for therapists and can be done on a PC or tablet.
✅ Free use: The Aphasia App is reimbursed by all statutory health insurance companies in Germany as an approved digital health application (DiGA) and registered medical device (PZN 18017082).
✅ Individualized therapy: Your therapist compiles words, sentences, and texts that match your personal interests and the severity of your aphasia.
✅ Practice anytime: Your individual practice sets can be used independently to practice understanding, speaking, reading, and writing.
✅ Easy to use: Clear photos, large interfaces, and numerous helpful features make the app very easy to use. No prior experience is necessary.
✅ Data privacy: Patient data is stored in Germany in accordance with GDPR security standards and protected by technical measures. A certified information security system according to ISO 27001 is in place.
✅ Highest quality standards: The app was developed specifically for the needs of patients by a team of speech therapists and computer scientists at Ludwig Maximilian University of Munich and is registered as a medical device.
✅ ✅ Diverse practice aids: Video with mouth-reading and pronunciation of the word, plus direct feedback on whether the answer was correct or incorrect
✅ Individual progress tracking: Automatic documentation with clear graphics and therapeutic adjustments to personal learning progress ensure optimal training without over- or under-challenging the user.
------
Purpose: neolexon Aphasia offers digital speech therapy for patients with aphasia and/or apraxia of speech who have language impairments due to a neurological condition. The digital application is designed to intensify speech therapy in a targeted manner and improve language skills. neolexon Aphasia is only to be used as a supplement to treatment by speech-language pathologists or speech therapists. The application is not intended to provide information for diagnostic or therapeutic decisions.
Important warnings:
Exclusion criteria: The app is not suitable for users with severe visual, motor, auditory, or cognitive impairments that prevent them from operating a tablet/computer. Language skills are not a prerequisite, as the application was developed for patients with aphasia of all severity levels.
Side effects: No adverse effects are currently known; however, if you experience any unexpected reactions, please contact your therapist or the manufacturer.
Software updates: Please install updates promptly, as mandatory updates will otherwise block further use of the app.
Secure password: Choose a password with at least 8 characters that does not contain tripled sequences or easily guessed combinations (e.g., "12345678" or "password"), use it exclusively for neolexon Aphasia, and change it immediately if you suspect it has been compromised.
Reporting obligations: Please report any serious incidents related to the app to the manufacturer and the relevant authority (Germany: BfArM; Switzerland: Swissmedic).
-------
Medical device data: Class I medical device according to MDR (EU) 2017/745; CH-Rep: Inspera AG, Thunstrasse 64, CH-3110 Münsingen
Patients with aphasia or speech apraxia train words, sentences & texts